RhumbLine Advisers
OPRX icon

RhumbLine Advisers’s OptimizeRx OPRX Stock Holding History

RhumbLine Advisers’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.8K Sell
8,015
-12,183
-60% -$70K ﹤0.01% 3696
2026
Q1 		$127K Sell
20,198
-7,253
-26% -$67.4K ﹤0.01% 3313
2025
Q4 		$337K Sell
27,451
-4,963
-15% -$81.1K ﹤0.01% 2902
2025
Q3 		$664K Sell
32,414
-3,668
-10% -$58.2K ﹤0.01% 2495
2025
Q2 		$487K Buy
36,082
+8,297
+30% +$90.8K ﹤0.01% 2696
2025
Q1 		$241K Buy
27,785
+2,636
+10% +$16.1K ﹤0.01% 3017
2024
Q4 		$122K Buy
25,149
+1,249
+5% +$6.98K ﹤0.01% 3418
2024
Q3 		$185K Sell
23,900
-7,562
-24% -$67.2K ﹤0.01% 3276
2024
Q2 		$315K Buy
31,462
+2,658
+9% +$29.2K ﹤0.01% 2969
2024
Q1 		$350K Buy
28,804
+660
+2% +$9.57K ﹤0.01% 2890
2023
Q4 		$403K Buy
28,144
+4,733
+20% +$45.4K ﹤0.01% 2791
2023
Q3 		$182K Buy
23,411
+484
+2% +$5.27K ﹤0.01% 3208
2023
Q2 		$328K Buy
22,927
+813
+4% +$11.6K ﹤0.01% 2951
2023
Q1 		$324K Sell
22,114
-26,340
-54% -$441K ﹤0.01% 2587
2022
Q4 		$814K Buy
48,454
+629
+1% +$10.9K ﹤0.01% 2243
2022
Q3 		$709K Buy
47,825
+1,954
+4% +$38.6K ﹤0.01% 2330
2022
Q2 		$1.26M Buy
45,871
+2,985
+7% +$88.5K ﹤0.01% 2030
2022
Q1 		$1.62M Buy
42,886
+4,878
+13% +$216K ﹤0.01% 1918
2021
Q4 		$2.36M Buy
38,008
+22,385
+143% +$1.7M ﹤0.01% 1786
2021
Q3 		$1.34M Buy
15,623
+817
+6% +$51.3K ﹤0.01% 2095
2021
Q2 		$916K Buy
14,806
+657
+5% +$33.4K ﹤0.01% 2282
2021
Q1 		$690K Buy
14,149
+767
+6% +$37K ﹤0.01% 2349
2020
Q4 		$417K Buy
13,382
+1,694
+14% +$41.5K ﹤0.01% 2508
2020
Q3 		$244K Sell
11,688
-513
-4% -$8.81K ﹤0.01% 2609
2020
Q2 		$159K Buy
12,201
+1,640
+16% +$17.8K ﹤0.01% 2849
2020
Q1 		$96K Hold
10,561
– – ﹤0.01% 2787
2019
Q4 		$108K Buy
+10,561
New +$120K ﹤0.01% 2868

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

RhumbLine Advisers's OPRX Position: Q2 2026 in Review

RhumbLine Advisers reduced its OptimizeRx (OPRX) stake by 60% in Q2 2026, selling an estimated $70K and leaving 8,015 shares worth $45.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3696.

RhumbLine Advisers first reported a position in OPRX in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.36M in Q4 2021. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • RhumbLine Advisers held 8,015 shares of OptimizeRx worth $45.8K as of Q2 2026.
  • RhumbLine Advisers sold 12,183 OptimizeRx shares in Q2 2026, an estimated $70K.
  • OptimizeRx made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3696 holding.
  • RhumbLine Advisers first reported a position in OptimizeRx in Q4 2019 and has held it in 27 quarters since.
  • RhumbLine Advisers's OptimizeRx position peaked at $2.36M in Q4 2021.
  • 113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.